市场调查报告书
商品编码
1402437
全球减重手术设备市场评估:依设备类型、依手术、依最终用户、按地区、机会、预测(2017-2031)Bariatric Surgery Devices Market Assessment, By Device Type, By Procedure, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
全球减重手术设备市场规模预计到2023年将达到22.1亿美元,到2031年将达到33.8亿美元,2024-2031年预测期间复合年增长率为5.44%。在医学进步和全球肥胖流行等多种因素的推动下,市场目前正在经历转型。肥胖和相关健康问题(包括糖尿病和心臟病)的流行显着增加了减重手术的需求。此外,技术和手术技术的进步引入了创新设备,提高了减肥手术的效率和安全性。在世界各地,每年有近 58 万人接受减重手术。除了减重之外,这些手术还可以显着改善许多与肥胖相关的健康问题,包括第 2 型糖尿病。儘管市场预计将成长,但它面临着监管审批、手术成本和减肥药物上市的挑战。因此,市场充满机会和挑战,成长速度预计将保持强劲,反映出解决肥胖问题的迫切需求。
该市场显示出显着增长,主要是由于肥胖及其相关併发症的流行。肥胖是第五大死因。随着肥胖症在全球持续增加,糖尿病、心血管疾病和代谢紊乱等疾病的发生率预计也会增加。减重手术已成为肥胖患者的重要治疗选择。随着医疗保健提供者努力改善患者的治疗效果和安全,减重手术需求的激增正在推动利用先进技术的创新减重手术设备的市场。
根据世界卫生组织 (WHO) 的数据,全球有超过 10 亿人被归类为肥胖,其中包括 6.5 亿成年人、3.4 亿年轻人和 3,900 万名儿童。数量还在持续增加。世界卫生组织预测,到2025年,大约1.67亿成人和儿童将因超重或肥胖而健康状况不佳。
减重手术设备技术的进步透过提高准确性和患者治疗结果彻底改变了市场。机器人辅助手术系统的使用使外科医生能够在手术过程中获得精确度和控制力。这些机器人系统提供手术部位的可视化、增加的灵活性以及处理传统腹腔镜工具被认为困难或不可能的复杂手术的能力。此外,新型 Obalon 球囊和腹腔镜可调节胃束带等微创治疗方法正在获得认可,并正在彻底改变减重手术。这些手术涉及小切口和专用器械,可显着减少对周围组织的损伤,与开放性手术相比,疼痛更轻,恢復更快,併发症也更少。此外,加速復健外科(ERAS)方案的采用,包括贯穿整个手术过程的基于证据的策略,对于最大限度地减少併发症和促进康復至关重要,并且是该领域的持续趋势。是没有进化。
从设备类型来看,微创手术设备已成为微创和非侵入性手术的主导部分。这些设备为传统开放性手术提供了一种侵入性较小的替代方案,从而彻底改变了手术领域,从而减少了患者的创伤,缩短了恢復时间并减少了併发症。微创手术设备包括腹腔镜、套管针、机器人辅助系统等多种工具和设备,大大提高了手术过程的精确度、视觉化和效率。由于其多功能性和经过验证的优点,它受到许多外科医生的青睐,并在微创和非侵入性手术中占有重要的市场份额。
北美在全球市场中地位突出,一直占最高份额。这是由于多种因素强调了该地区在行业中的主导地位。北美肥胖及相关疾病的盛行率很高,这推动了对减重手术以及减重手术设备的需求。该地区强大的医疗基础设施、创新技术和熟练的医务人员进一步巩固了该地区在减肥手术领域的领先地位。
此外,广泛的研发活动以及对医疗创新的关注,导致先进减重手术设备的不断发展和采用。美国 FDA 等监管机构在加速审批、确保安全标准、创造有利于市场成长的环境方面发挥着至关重要的作用。随着人们对肥胖相关健康风险的认识不断提高以及减肥手术的好处变得更加明显,北美市场预计将保持其在全球格局中的突出地位。
本报告研究和分析了全球减重手术设备市场,提供市场规模和预测、市场动态以及主要参与者的现状和前景。
With a CAGR of 5.44% for the forecast period between 2024 and 2031F, the size of the global market for bariatric surgical equipment was estimated at USD 2.21 billion in 2023 and is projected to reach USD 3.38 billion in 2031. The global market for bariatric surgery devices is currently undergoing a transformative phase, driven by a combination of factors that reflect the evolving landscape of healthcare and the growing prevalence of obesity around the globe. The demand for bariatric procedures is growing significantly due to the increasing prevalence of obesity and associated health problems including diabetes and heart disease. Additionally, ongoing advancements in technology and surgical techniques have introduced innovative devices that enhance the efficiency and safety of bariatric procedures. Globally, close to 580,000 individuals undergo bariatric surgery every year. Besides weight loss, these surgical procedures lead to substantial improvements of numerous health issues associated with obesity such as type 2 diabetes. Despite the promise of growth, the market faces challenges related to regulatory approvals, cost of procedure, and the launch of weight loss drugs. As a result, the market exhibits a dynamic landscape with opportunities and challenges, and the pace of growth is expected to remain strong, reflecting the urgency of addressing obesity.
The global bariatric surgery devices market is experiencing substantial growth, primarily due to the increasing prevalence of obesity and associated health complications. Obesity is the fifth leading cause of death. As obesity continues to rise worldwide, the incidence of conditions like diabetes, cardiovascular diseases, and metabolic disorders will increase. Bariatric surgery has become an important treatment option for obese patients. The surge in demand for bariatric procedures has driven the market for innovative and technologically advanced bariatric surgery devices, as healthcare providers strive to enhance patient outcomes and safety.
According to the World Health Organization (WHO), there are over 1 billion individuals globally who are classified as obese, comprising 650 million adults, 340 million adolescents, and 39 million children. The number is on a continual rise. WHO projects by 2025, around 167 million people, spanning both adults and children, will experience deteriorating health due to excess weight or obesity.
Technological advancements in bariatric surgery devices have revolutionized the market by enhancing precision and patient outcomes. The utilization of robotic-assisted surgery systems has allowed surgeons to achieve precision and control during procedures. These robotic systems offer improved visualization of surgical area, enhanced dexterity, and the ability to tackle complex surgeries that were once considered challenging or impossible with traditional laparoscopic tools. Moreover, the growing acceptance of minimally invasive treatments, such the novel obalon balloon and laparoscopic adjustable gastric banding, has revolutionized bariatric surgery. These techniques, involving small incisions and specialized instruments, significantly reduce trauma to surrounding tissues, leading to reduced pain, faster recovery, and fewer complications compared to open surgery. Additionally, the adoption of Enhanced Recovery After Surgery (ERAS) protocols, which consists of evidence-based strategies throughout the surgical journey, has been pivotal in minimizing complications and expediting recovery, further emphasizing the continual evolution of the field.
In July 2023, leading medical device manufacturer Genesis MedTech announced that the National Medical Products Administration (NMPA) of China approved the market release of its groundbreaking ArtiSential line of articulating laparoscopic instruments. With its ability to replicate a surgeon's wrist and finger movements, ArtiSential is a laparoscopic surgical instrument that offers several clinical benefits that improve surgical accuracy and results. The double-joint end-effector offers complete access to slender surgical sites with 360 degrees of rotation. The surgeon can experience an authentic endoscopic procedure due to its fully mechanical operation and tactile feedback conduction.
Based on device type, minimally invasive surgical devices have emerged as the dominant segment, amongst minimally invasive and non-invasive surgical procedures. These devices have revolutionized the field of surgery, as they offer less invasive alternatives to traditional open surgeries, resulting in reduced trauma to patients, shorter recovery times, and fewer complications. Minimally invasive surgical devices encompass a wide array of tools and equipment, including laparoscopes, trocars, and robotic-assisted systems, which have significantly enhanced the precision, visualization, and efficiency of surgical procedures. Their versatility and proven benefits have made them preferred choice for many surgeons, contributing to their substantial market share in both minimally invasive and non-invasive surgical settings.
North America holds a prominent position in the global bariatric surgery device market, consistently accounting for the highest share. It is attributed to several key factors that underscore the region's dominance in the industry. North America has high prevalence of obesity and related health conditions, which drives the demand for bariatric surgeries and, consequently, bariatric surgery devices. The region's robust healthcare infrastructure, innovative technology, and skilled medical professionals further contribute to its leadership in the field of bariatric surgery.
Moreover, extensive research and development activities, alongside a strong emphasis on healthcare innovation, have resulted in continuous evolution and adoption of advanced bariatric surgery devices. Regulatory bodies, such as FDA in the United States, play a pivotal role in expediting approvals and ensuring safety standards, fostering an environment conducive to market growth. As awareness about the health risks associated with obesity continue to grow and the benefits of bariatric surgery become more apparent, North American market for bariatric surgery devices is expected to maintain its prominent position in the global landscape.
Like many sectors of the healthcare industry, the global bariatric surgery devices market experienced a significant impact due to the COVID-19 pandemic. At the beginning of the pandemic, there was a sharp decrease in bariatric surgical procedures conducted globally. As hospitals and healthcare facilities worldwide redirected their resources and focused on the urgent needs of COVID-19 patients, the volume of elective and non-urgent surgeries, including bariatric procedures, declined. Restrictions on non-essential medical procedures, coupled with concerns over virus transmission, led to the postponement or cancellation of many bariatric surgeries. It resulted in a temporary reduction in demand for bariatric surgery devices and associated equipment. One-fifth of surgeons expressed hesitation to resume bariatric surgeries until the COVID-19 pandemic had ended completely.
The global bariatric surgery devices market is a fast-growing competitive market, with major players like Intuitive Surgical Inc., Johnson & Johnson, SPATZ FIGA, Inc., etc. These companies have innovative and technologically advanced solutions, robust research and development, and significant market shares. With the rising demand for minimally invasive surgeries, the market players are producing better solutions. The global bariatric surgery devices market is expected to grow, driven by the growing prevalence of obesity and related disorders, increasing preference for minimally invasive surgery and technological advancement.
In May 2023, Olympus announced the market release of POWERSEALTM Sealer/Divider for Europe, Middle East, and Africa (EMEA). This versatile and advanced bipolar device provides state-of-the-art sealing, dissection, and grasping capabilities for surgeons specializing in various medical fields, catering to both laparoscopic and open surgical procedures. It enhances Olympus' advanced energy portfolio, complementing the unique hybrid technology of THUNDERBEAT, further strengthening their offerings.
In May 2021, Standard Bariatrics announced the US Food and Drug Administration granting clearance for its innovative Titan SGS stapling technology, which is uniquely tailored for bariatric sleeve surgery. The groundbreaking design of the Titan SGS provides surgeons conducting sleeve gastrectomy procedures with the longest continuous staple cutline in the industry, with a length of 23 centimeters.
All segments will be provided for all regions and countries covered:
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.